Internal Medicine, Medical Oncology · Clive, IA
NPI
1356584080
Since 2009
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
12495 University Ave Ste 200
Clive, IA, 50325
Phone (515) 282-2921
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.8M
208,423 services
Medicare patients, 2024
1,013
Average age 74
Drug cost, 2024
$5.9M
2,257 prescriptions
Company payments, 2025
$138K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tara M Graff was code J9271 (injection, pembrolizumab, 1 mg), 21,300 times for 37 patients. In total Tara M Graff billed 208,423 services in 184 codes, and Medicare paid $3.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,300 | 37 | $38.42 | $818K |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 16,560 | 20 | $0.37 | $6,099 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 13,260 | 18 | $0.28 | $3,697 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 10,260 | 16 | $39.13 | $401K |
| J0897 Injection, denosumab, 1 mg | Office | 9,720 | 79 | $20.21 | $196K |
| J0185 Injection, aprepitant, 1 mg | Office | 7,800 | 24 | $1.34 | $10K |
| J9267 Injection, paclitaxel, 1 mg | Office | 7,060 | 12 | $0.08 | $554 |
| J1756 Injection, iron sucrose, 1 mg | Office | 5,900 | 22 | $0.17 | $1,002 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,230 | 23 | $37.95 | $161K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,910 | 81 | $0.09 | $256 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 2,904 | 14 | $21.13 | $61K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 2,168 | 90 | $0.07 | $156 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,490 | 14 | $34.24 | $51K |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 1,490 | 15 | $31.27 | $47K |
| 85025 Blood Count | Office | 1,395 | 455 | $7.61 | $11K |
By year: 2022 $3.3M for 211,712 services; 2023 $2.9M for 181,330 services; 2024 $3.8M for 208,423 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,395 | 455 | $7.61 | $11K |
| 80053 Clinical Chemistry | 1,260 | 443 | $10.33 | $13K |
| 36415 Venipuncture Blood Collection | 1,145 | 427 | $8.65 | $9,904 |
| 82784 Immunoassay | 843 | 112 | $9.11 | $7,683 |
| 84100 Clinical Chemistry | 620 | 294 | $4.63 | $2,869 |
| 84550 Clinical Chemistry | 566 | 272 | $4.41 | $2,494 |
| 83615 Clinical Chemistry | 555 | 275 | $5.89 | $3,271 |
| 82728 Clinical Chemistry | 228 | 95 | $13.36 | $3,046 |
| 82607 Clinical Chemistry | 173 | 113 | $14.78 | $2,557 |
| 82746 Clinical Chemistry | 172 | 112 | $14.38 | $2,473 |
Medicare prescription drug claims, 2024
In 2024, the drug Tara M Graff prescribed most often to Medicare patients was Acyclovir, with 320 prescriptions and refills. In total Tara M Graff wrote 2,257 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 320 | 440 | 54 | $3,489 |
| Anastrozole Generic | 301 | 767 | 103 | $4,240 |
| Letrozole Generic | 210 | 444 | 63 | $4,132 |
| Calquence Acalabrutinib Maleate | 138 | 138 | 13 | $2.0M |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 98 | 125 | 21 | $569 |
| Dexamethasone Generic | 84 | 86 | 20 | $1,445 |
| Lenalidomide Generic | 79 | 79 | Under 11 | $989K |
| Tamoxifen Citrate Generic | 75 | 199 | 25 | $2,319 |
| Eliquis Apixaban | 70 | 89 | 17 | $51K |
| Potassium Chloride Generic | 64 | 85 | 18 | $851 |
| Hydroxyurea Generic | 52 | 75 | 14 | $769 |
| Prednisone Generic | 49 | 64 | 15 | $236 |
| Gabapentin Generic | 49 | 55 | Under 11 | $468 |
| Prochlorperazine Maleate Generic | 48 | 48 | 20 | $324 |
| Brukinsa Zanubrutinib | 42 | 42 | Under 11 | $593K |
Brand drugs: 417 claims; generic drugs: 1,840 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tara M Graff $138K ($138K in general payments such as food, travel and fees and $18.82 for research) from 21 companies. The largest payer was Abbvie Inc. with $37K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 33 | $37K |
| Genmab U.S., Inc. GMAB | 32 | $20K |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $19K |
| Incyte Corporation INCY | 10 | $15K |
| Genentech USA, Inc. ROG.SW | 18 | $12K |
| Janssen Research & Development, LLC JNJ | 1 | $11K |
| BeOne Medicines USA, Inc. ONC | 10 | $10K |
| Lilly USA, LLC LLY | 4 | $6,696 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $3,973 |
| AstraZeneca UK Limited AZN | 2 | $3,280 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.